Phase IIA

Bone Therapeutics Reports Initial Efficacy Results from Its PREOB® Phase IIA Trial in Severe Osteoporosis

BONE THERAPEUTICS  (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in…